← feed

Is NCT06245902 results overdue?

Yes — results are overdue. Primary completion was 2018-02-08; the FDAAA-801 reporting deadline (2019-02-08) passed 2736 days ago and no results are posted on ClinicalTrials.gov.

An Acute Migraine Factorial Study

NCT IDNCT06245902 ↗
SponsorAllodynic Therapeutics, Inc (INDUSTRY)
PhasePHASE2
StatusCOMPLETED
Primary completion2018-02-08 (ACTUAL)
Reporting deadline2019-02-08 (completion + 365d)
Days overdue2736
Results postedNo — check results tab ↗
FDA-regulateddrug: yes, device: no
ProvenanceFlagged overdue on 2026-06-21 · SHA-256 a52b510ece527b78… (hash-chained, tamper-evident)

Source of record: ClinicalTrials.gov NCT06245902. The reporting requirement is FDAAA 801 (Public Law 110-85 §801) and the Final Rule, 42 CFR Part 11.

⚠ Public-record facts from ClinicalTrials.gov — not a finding of violation, fraud, or non-compliance, and not legal or investment advice. Full disclaimer →